A human pancreatic b-cell line that is functionally equivalent to primary b-cells has not been available. We established a reversibly immortalized human b-cell clone (NAKT-15) by transfection of primary human b-cells with a retroviral vector containing simian virus 40 large T-antigen (SV40T) and human telomerase reverse transcriptase (hTERT) cDNAs flanked by paired loxP recombination targets, which allow deletion of SV40T and TERT by Cre recombinase. Reverted NAKT-15 cells expressed b-cell transcription factors (Isl-1, Pax 6, Nkx 6.1, Pdx-1), prohormone convertases 1/3 and 2, and secretory granule proteins, and secreted insulin in response to glucose, similar to normal human islets. Transplantation of NAKT-15 cells into streptozotocin-induced diabetic severe combined immunodeficiency mice resulted in perfect control of blood glucose within 2 weeks; mice remained normoglycemic for longer than 30 weeks. The establishment of this cell line is one step toward a potential cure of diabetes by transplantation.
Type 1 diabetes results from the destruction of insulin-producing pancreatic b-cells by T cell-mediated autoimmune responses 1 . Exogenous insulin is used for the control of blood glucose in diabetic patients; however, hypoglycemic episodes are unavoidable. Over the last several decades, islet transplantation has been developed as a promising method to achieve strict control of blood glucose and a potential cure for type 1 diabetes 2, 3 . Given the shortage of donor pancreata, alternative sources of islets have been sought in stem cells [4] [5] [6] , porcine islets 7 and b-cell expansion with growth factors 8, 9 . However, differentiation and expansion of embryonic and pancreatic stem cells and expansion of differentiated b-cells in vitro is limited 10 . Expansion of primary b-cells by growth factors is also hampered by the senescence of the cells 11 . Immortalization of purified b-cells by the addition of genes such as TERT could allow the cells to grow indefinitely; however, immortalized b-cell lines established in this way lose their differentiated function 12 .
This investigation was initiated to establish a human pancreatic b-cell line that is functionally equivalent to primary b-cells and can yield large amounts of cells for transplantation. Our strategy was to transform human primary b-cells with immortalizing genes and screen for clones that were not tumorigenic and that expressed insulin and b-cell-associated factors. Suitable clones could then be expanded, and Cre-mediated excision of the immortalizing genes would allow removal of tumorigenic potential and recovery of primary b-cell function. We now report that our reversibly immortalized pancreatic b-cell clone (NAKT-15) secretes insulin in response to glucose stimulation and nonglucose secretagogues, and expresses proteins characteristic of b-cells, such as Isl-1, Pax 6, Nkx 6.1, Pdx-1, prohormone convertase (PC) 1/3, PC 2, and secretory granule proteins such as chromogranin A and synaptophysin. NAKT-15 cells did not senesce after 450 passages in culture and could be continuously expanded. Transplantation of reverted NAKT-15 cells into streptozotocin (STZ)-induced diabetic severe combined immunodeficiency (SCID) mice resulted in perfect control of blood glucose for a prolonged time without hypoglycemia. Reversibly immortalized pancreatic b-cells may overcome the limitation of primary pancreatic b-cells for transplantation to control type 1 diabetes.
RESULTS

Reversibly immortalized human b cells (NAKT-15 cells)
To establish an immortalized human pancreatic b-cell line, we transduced freshly isolated human pancreatic islet cells with an SV40T-expressing retroviral vector, SSR#69, and applied hygromycin (100 mg/ml) selection. We then added Newport Green dye to the cell culture and recovered Newport Green-positive cells by a MoFlo cell sorter to select b-cells. We superinfected Newport Green-positive cells with a retroviral vector, SSR#197, expressing hTERT and enhanced green fluorescent protein (EGFP) to immortalize and mark the cells (Fig. 1) . We screened a total of 271 clones for tumorigenicity by inoculating 1 Â 10 6 cells of each clone into SCID mice and found that 253 clones were nontumorigenic. We examined the expression of insulin and Isl-1, Pax 6, Nkx 6.1, and Pdx-1 by reverse transcription (RT) PCR analysis and found that only one clone, designated NAKT-15, expressed all of these factors and insulin (Supplementary Table 1 online).
To remove the immortalizing genes, SV40T and TERT, from NAKT-15 cells, we infected NAKT-15 cells with a Cre-expressing recombinant adenovirus vector at multiplicity of infection (MOI) 10. We first selected reverted NAKT-15 cells by G418 (100 mg/ml) treatment, as the NeoR gene is expressed after loxP recombination 13 , which removed SV40T-expressing cells. In addition, we treated the cells with 5 mM ganciclovir to confirm the removal of SV40T-expressing cells. Finally, we sorted EGFP-negative cells using MoFlo. We obtained reverted NAKT-15 cells for further characterization and for in vivo tests of functionality (Fig. 1) .
Characterization of reverted NAKT-15 cells
We confirmed by RT-PCR analysis that the reverted NAKT-15 cells did not express either SV40T or TERT (Fig. 2a) . Next, we examined the expression of b-cell-specific transcription factors, expression of the insulin gene, intranuclear Pdx-1, cell aggregate morphology, glucoseresponsive insulin secretion, insulin and C-peptide content and tumorigenicity. Isl-1, Pax 6, Nkx 6.1, and Pdx-1 were expressed more strongly in reverted NAKT-15 cells than in immortalized NAKT-15 cells, as determined by northern (Fig. 2b) and western ( Fig. 2c) blot analysis, but less strongly than in normal human islets ( Fig. 2b,c; Supplementary Fig. 1a,b online) . Real-time RT-PCR analysis yielded comparable results ( Supplementary Fig. 2a online) . Figure 1 Scheme for the establishment of reversibly immortalized human b-cell lines. Freshly isolated human islets were cultured in monolayer and transduced with the retroviral vector SSR#69. After hygromycin selection of SSR#69-transduced cells, Newport Green dye was added and Newport Greenpositive cells were sorted. After transduction with SSR#197, EGFP-positive cells were sorted and subjected to single-cell cloning, yielding the clone NAKT-15. Transient expression of Cre recombinase was induced by infecting cells with a recombinant adenovirus expressing Cre recombinase (AxCANCre), which removed the SV40T and TERT genes that were flanked by loxP sites. Neomycin (G418) selection and EGFP-negative cell sorting resulted in the collection of reverted NAKT-15 cells. CAG, promoter consisting of cytomegalovirus IE enhancer, chicken b-actin promoter, and rabbit b-globin polyadenylation signal; HSV-TK, herpes simplex virus thymidine kinase; HygroR, hygromycin-resistance gene; IRES, internal ribosomal entry site; MoMLV LTR, long terminal repeat of Moloney murine leukemia virus leader sequence; NCre, nuclear localizing signal-tagged Cre recombinase; pA, polyadenylation signal; j, packaging signal. Other abbreviations are defined in the text.
Electrophoretic mobility shift assay for Pdx-1 binding activity in the reverted NAKT-15 cells showed that incubation of the nuclear extract with an oligonucleotide containing the Pdx-1 binding site shifted the band, and addition of anti-Pdx-1 antibody shifted it further (Fig. 2d) . This result indicates that Pdx-1 is expressed in the reverted NAKT-15 cells and binds to the binding site for Pdx-1. Expression of the insulinprocessing enzymes PC 1/3 and PC 2 and the secretory granule proteins chromogranin A and synaptophysin was also observed in immortalized and reverted NAKT-15 cells, with much stronger expression in the reverted cells (Fig. 2c, Supplementary Fig. 1b online) . Neither immortalized nor reverted NAKT-15 cells produced non-bcell hormones such as glucagon and somatostatin, whereas human islets containing other endocrine cells clearly produced these proteins (Fig. 2c, Supplementary Fig. 1b online) . Taken together, these results indicate that NAKT-15 cells have the characteristics of primary b-cells.
We then evaluated the ability of reverted NAKT-15 cells to produce and secrete insulin in vitro. Insulin mRNA and protein were more strongly expressed in reverted cells than in immortalized NAKT-15 cells, although less than in normal islets (B40% of that in normal islets Fig. 2b,c ; Supplementary Figs. 1a,b and 2a, online). The secretion of insulin into the medium from reverted NAKT-15 cells in response to glucose was dose dependent, and increased 7.9-fold in high glucose (25 mM) as compared with low glucose (5.6 mM) (Supplementary Table 2 online). To determine whether reverted NAKT-15 cells respond to nonglucose secretagogues, we examined insulin secretion after treatment with tolbutamide, forskolin, KCl, glucagon-like peptide-1 (GLP-1), or a free fatty acid, palmitate, in the presence of various concentrations of glucose. Treatment of NAKT-15 cells with all these secretagogues, except palmitate, resulted in the potentiation of insulin secretion in the presence of low and medium (10 mM) glucose concentrations. In palmitate-treated NAKT-15 cells, insulin secretion was potentiated in the presence of medium but not low glucose concentrations. In the presence of high glucose, insulin secretion from NAKT-15 cells was not potentiated when nonglucose secretagogues were added, probably because insulin secretion is saturated in the presence of high glucose (Supplementary Table 3 online). The magnitude of these increases was similar to that found in control human islets, although the absolute amount of insulin secretion was lower. The insulin and C-peptide content in reverted NAKT-15 cells was approximately 40% the amount in control human islets (Supplementary Table 2 content. When we cultured reverted NAKT-15 cells on Matrigel, the cells formed an aggregate after 24 h (Fig. 3b) and showed a structure similar to primary pancreatic islets after 48 h (Fig. 3c) .
Immunohistochemical staining of these cells clearly showed expression of both insulin and Pdx-1 ( Fig. 3d-f ). Aggregated cells showed enhanced production of insulin ( Fig. 3e ,f) as compared with dispersed cells (Fig. 3d) . Immunoelectron microscopic examination showed that the reverted NAKT-15 cells contained a number of secretory granules with dense cores and surrounding spaces (Fig. 3g) . Insulin-stained granules (gold particles) were seen in the core of the granules in the reverted NAKT-15 cells (Fig. 3h) . This was similar to the dense cores ( Fig. 3i ) and secretory granules ( 
Remission of diabetes by transplantation of NAKT-15 cells
To evaluate the functionality of reverted NAKT-15 cells in vivo, we transplanted 3 Â 10 6 cells (which is the approximate number of b-cells in 2,000 human islets) into the subrenal capsule of STZ-induced diabetic SCID mice and examined blood glucose levels thereafter. Blood glucose levels fell to normal within 2 weeks of transplantation and remained normal for 30 weeks without any hypoglycemia. In contrast, nontransplanted animals remained hyperglycemic (Fig. 4a) . Diabetic mice transplanted with 2,000 normal human islets, as a control, showed lowered blood glucose levels within 1 week. Blood glucose was maintained at 68.0 ± 6.8 mg/dl thereafter, which is lower than the levels seen in mice transplanted with NAKT-15 cells or in normal, healthy mice (Fig. 4a) . Furthermore, NAKT-15 cell-transplanted mice survived until the end of the experiment, whereas all of the nontransplanted animals died within 10 weeks (Fig. 4b) . To verify that the transplanted NAKT-15 cells were responsible for the control of blood glucose levels, we removed the graft-bearing kidney from the mice and found that blood glucose levels increased immediately after graft removal (Fig. 4a) , suggesting that insulin produced from transplanted NAKT-15 cells was responsible for the control of glucose levels.
To determine whether reverted NAKT-15 cells properly secrete insulin when blood glucose levels increase, we carried out intraperitoneal glucose tolerance tests on NAKT-15 cell-transplanted SCID mice at 10 weeks after transplantation. The kinetics of glucose clearance were similar to those of mice transplanted with normal human islets, although the blood glucose levels were higher at all time points than in mice transplanted with human islets. In contrast, untreated diabetic SCID mice remained hyperglycemic (Fig. 4c) .
To confirm glucose-responsive insulin secretion in NAKT-15 celltransplanted mice, we measured both human insulin and human C-peptide levels in the serum of these mice before and after glucose injection. After glucose injection, serum insulin and C-peptide levels increased, comparable with increases seen in mice transplanted with normal human islets. Mouse insulin and C-peptide, but not human insulin or C-peptide, were detected in the serum of normal mice ( Table 1) .
To determine whether transplanted NAKT-15 cells kept their original characteristics after transplantation, we removed the graft from the kidney capsule at 30 weeks after transplantation and checked expression of the immortalizing genes, SV40T and TERT, expression of b-cell-specific transcription factors, and production and secretion of insulin. The expression of SV40T and hTERT was not detected (Fig. 5a) . Interestingly, the expression of b-cell transcription factors such as Isl-1, Pax 6, Nkx 6.1, and Pdx-1 and insulin, as analyzed by northern blot analysis, real-time RT-PCR and western blot analysis was substantially higher in the removed graft than in NAKT-15 cells in vitro (Fig. 5b,c and Supplementary Figs. 1c,d and 2b online) . When we measured the insulin and C-peptide content in NAKT-15 cells removed at 30 weeks after transplantation, the amount of insulin and C-peptide was approximately 60% and 61%, respectively, of that of transplanted normal human islets (Fig. 5d,e) . The insulin and C-peptide content of the grafted NAKT-15 cells was about 1.5-fold higher than that of NAKT-15 cells in vitro (Supplementary Table 2 online).
Animals were killed and the transplanted cells in the subrenal capsule were examined for insulin expression by anti-insulin antibody staining. Transplanted NAKT-15 cells were positive for insulin expression (Fig. 6a,b ,e) and contained insulin secretory granules, as observed by immunoelectron microscopy (Fig. 6k,l) . In contrast, the pancreatic islets of the same animals were insulin negative (Fig. 6f ) and glucagon positive (Fig. 6g) , indicating that b-cells were destroyed by STZ treatment. Glucagon-expressing cells were relocalized into the center of the islets in these mice, probably owing to the depletion of b-cells, whereas glucagon-expressing cells were localized in the periphery of the islets of normal mice (Fig. 6j) . We also examined the liver for insulin-positive cells and failed to detect any (Fig. 6k,l) . Finally, our examination of the liver, kidney, heart, spleen, brain, stomach and intestine of mice transplanted with reverted NAKT-15 cells revealed no tumor development in any of those organs (data not shown). T r a n s p la n t e d T r a n s p la n t e d T r a n s p la n t e d T r a n s p la n t e d T r a n s p la n t e d functionality of b-cells 10, 21 and produced insulin in response to glucose, nonglucose secretagogues and physiological potentiators of glucose-responsive insulin secretion, indicating that they have primary b-cell function. NAKT-15 cells reverted at different times during passage consistently showed b-cell characteristics ( Supplementary  Fig. 4 12 . In our study, we first screened the immortalized clones and selected the clone that did not have tumorigenicity in vivo. Then the immortalizing genes, SV40T and TERT, were deleted by infecting the cells with recombinant adenovirus expressing Cre recombinase. Cultivation of these transduced cells in medium containing G418, a neomycin analog, removed SV40T-positive cells. In addition, selection of EGFP-negative cells allowed purification of cells from which TERT and the associated EGFP gene has been removed. Our immortalizing system also has redundant safeguards by provision of a suicide gene, herpes simplex thymidine kinase (HSV-TK). Addition of ganciclovir to cells containing the HSV-TK gene will convert ganciclovir to a toxic metabolite that kills HSV-TK-containing cells. Ganciclovir treatment (5 mM) of immortalized NAKT-15 cells resulted in their death within 10 d, whereas reverted cells survived. These multiple selection systems should remove any tumorigenicity from our b-cell line. NAKT-15 cells reverted in this way at three different time points during passage showed neither SV40T nor hTERT expression, lost their proliferative capacity and did not cause tumors to develop in SCID mice ( Supplementary Fig. 3 online) . Even with this strict selection procedure, the possibility of tumorigenesis still remains owing to the possibility of epigenetic changes, chromosomal instability or mutation during the culture of the immortalized cells. Evaluation of possible tumorigenic potential by analysis of changes in methylation of MINT2 (Methylated in Tumor 2) 24 , MINT31 (Methylated in Tumor 31) 24 , MGMT (O 6 -methylguanine-DNA methyltransferase) 25 , hMLH1 (mismatch repair genes human mutL homolog 1) 25 and RUNX3 (Runt-related transcription factor 3) 26 may be necessary. Our data regarding SSR#197-immortalized human hepatocytes have suggested that DNA methylation status, such as widespread methylation of MGMT and demethylation of MINT31, is one parameter that can be used to predict the malignancy of the immortalized hepatocyte cell line (unpublished data). Nevertheless, our reversibly immortalized human pancreatic b-cell line, NAKT-15, has not shown any sign of tumorigenicity when the cells were transplanted into SCID mice.
DISCUSSION
One advantage of our immortalized cells is that further genetic manipulations should be relatively easy compared to primary b-cells because they divide actively. Thus, it may be possible to confer protection from autoimmune attack genetically engineering the b-cell line before transplantation 27, 28 . Expression of immunosuppressive cytokines such as interleukin (IL)-4, IL-10 or transforming growth factor-b, expression of anti-apoptotic molecules such as Bcl-2 or A20, or expression of FasL may render the b-cell line resistant to immune attack. Blocking costimulation by expression of cytotoxic T lymphocyte-associated antigen-4 or CD40-Ig and the expression of growth factors such as hepatocyte growth factor may also improve the transplantation outcome.
In this study, we have established a human pancreatic b-cell line that appears functionally equivalent to primary pancreatic b-cells and that does not senesce after multiple passages. This cell line offers continuous availability, uniformity and sterility, and may provide a source of b-cells for the treatment of type 1 diabetic patients by transplantation.
METHODS
Immortalization of human pancreatic b-cells. Human islets isolated from a brain-dead donor were provided by the University of Alberta [29] [30] [31] . We hand picked healthy islets under a stereomicroscope and seeded them in T25 flasks (tissue culture flask; Becton Dickinson Labware) for monolayer culture in William's E medium (Sigma) containing 10% fetal calf serum, 10 mM nicotinamide, 10 -7 mol/l insulin, 10 -6 mol/l dexamethasone, 25 mg/l epidermal growth factor and penicillin G/streptomycin. The flasks were coated with extracellular matrix derived from a rat bladder carcinoma cell line 804G (kindly provided by R. Oyasu, Northwestern University School of Medicine, Chicago, IL, USA) in the presence of 0.1 mmol/l IBMX (Wako Pure Chemical Industries). The monolayer-cultured islet cells were infected with a retroviral vector, SSR#69, encoding SV40T and the hygromycin-resistance gene between a pair of loxP recombination targets 32 . Ten days after the SSR#69 infection, the medium was replaced with low glucose DMEM (GIBCO) containing 10% fetal calf serum, 10 mM nicotinamide, 10 mM troglitazone (Calbiochem) 19 , 100 mg/ml hygromycin (Calbiochem) and penicillin G/streptomycin. After hygromycin selection, Newport Green diacetate cell-permeant dye (Molecular Probes) 33 was added to the culture medium and Newport Green-positive cells were recovered using a MoFlo cell sorter (DakoCytomation) to select b-cell-enriched populations. These Newport Green-positive cells were infected with a retroviral vector, SSR#197, coding for hTERT and EGFP cDNAs between a pair of loxP recombination targets for Cre recombinase 34 . EGFP-positive cells were sorted by MoFlo and single cells were cloned with an automated cloner. The tumorigenicity of 271 clones was screened in vivo by transplantation of the cells into SCID mice; 18 clones were tumorigenic.
To evaluate the gene expression of Isl-1, Nkx 6.1, Pax 6 and Pdx-1, transcription factors specific to pancreatic b-cells, and insulin at the mRNA level, we performed RT-PCR analysis, as previously reported [35] [36] [37] . Out of 253 nontumorigenic clones, clone no. 15 (NAKT-15) was positive for expression of all these genes and was selected for further study.
Reversion of NAKT-15 cells. To remove the SV40T and TERT genes from NAKT-15 cells, the cells were first infected with AxCANCre (obtained from Rikken Gene Bank) 22 at an MOI of 10 for 2 h. G418 (100 mg/ml) (Gibco) was added 48 h later, and the cells were cultured for 14 d and treated with ganciclovir (5 mM), after which EGFP-negative cells were sorted by MoFlo. We used Matrigel Matrix (BD Biosciences) to accelerate aggregation formation of NAKT-15 cells. The cells were cultured in dishes containing Matrigel with serum-free, insulin-free culture medium (ISE-RPMI) 38 and used for experiments. Gene expression of SV40T and hTERT and b-actin as an internal control was evaluated in reverted NAKT-15 cells by RT-PCR. Primers used were SV40T (420 bp), sense strand, 5¢-CAGGCATAGAGTGTCTGC-3¢, antisense strand, 5¢-CAACAGCCTGTTGGCATATG-3¢; hTERT (451 bp), sense strand, 5¢-CTGACCAGGGTCCTATTCCA-3¢, antisense strand, 5¢-TGGTTATCCCAAG CAAGAGG-3¢; and b-actin (508 bp), sense strand, 5¢-CATCGTGGGCCGCTCT AGGCAC-3¢, antisense strand, 5¢-CCGGCCAGCCAAGTCCAGGACGG-3¢. PCR was run for 30 cycles (Fig. 2a) or 40 cycles (Fig. 5a ) for SV40T and hTERT gene amplification.
Northern blot and real-time PCR analysis. RNA was isolated from immortalized and reverted NAKT-15 cells (population doubling level (PDL) 220-240), an immortalized human liver endothelial cell line (TMNK-1 cells, negative control) 13 , normal human pancreatic islets, grafted NAKT-15 cells and grafted human islets using RNAzol (Cinna/BioTecx). Northern blot analysis was performed as previously described 22 . Human cDNA fragments for the specific genes used as probes for the northern analysis were prepared by RT-PCR. Total RNA was isolated from human islets by the guanidinium thiocyanate-phenol method, and 1 mg RNA was used for cDNA synthesis. The resulting products were amplified using the following primers: insulin (433 bp), sense strand, 5¢-TCAAGCACATCACTGTCCTT-3¢, antisense strand, 5¢-GCTGGTTCAAGGG CTTTATT-3¢; Pdx-1 (578 bp), sense strand, 5¢-ATGAACGGCGAGGAG CAGTA-3¢, antisense strand, 5¢-GATCTTGATGTGTCTCTCGG-3¢; Nkx 6.1 (541 bp), sense strand, 5¢-ACACGGCATCAACAATATCC-3¢, antisense strand, 5¢-TCCCCAACGAATAGGCCAAA-3¢; Isl-1 (485 bp), sense strand, 5¢-AACGAG AAGCAGCTGCACAC-3¢, antisense strand, 5¢-CAGCCATCTTGCGTAGGT TG-3¢; Pax 6 (509 bp), sense strand, 5¢-GAATCAGCTCGGTGGTGTCT-3¢, antisense strand, 5¢-CAGCCATCTTGCGTAGGTTG-3¢; and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 694 bp), sense strand, 5¢-CAGCCTCAAG ATCATCAGCA-3¢, antisense strand, 5¢-TGAGGAGGGGAGATTCAGTG-3¢. Real-time RT-PCR assay for gene expression of characteristic b-cell transcription factors (Isl-1, Pax 6, Nkx 6.1 and Pdx-1) and insulin was carried out using a LightCycler instrument and a LightCycler FastStart DNA Master SYBR Green I kit (Roche Diagnostics), as previously reported 39 . All expression levels were normalized to GAPDH in each well. Expression was quantified as the ratio of the mRNA levels obtained from NAKT-15 cells to those of normal islets (normal human islets ¼ 1).
Western blot analysis. Total cell extracts were prepared from immortalized and reverted NAKT-15 cells (PDL 220-240), grafted NAKT-15 cells, grafted human islets and an immortalized human liver endothelial cell line (TMNK-1 cells, negative control) 13 and western blot analysis was carried out as previously described 13 using rabbit anti-human PC 1/3, rabbit anti-human PC 2 (Chemicon), or rabbit anti-human Pax 6 antibody, goat anti-human Nkx 6.1 antibody, goat anti-human glucagon, goat anti-human chromogranin A, or goat anti-human synaptophysin antibodies (Santa Cruz Biotechnology). Horseradish peroxidase-conjugated anti-rabbit or anti-goat IgG (Cell Signaling Technology) was used as a secondary antibody. Protein bands were detected by a chemiluminescence system (ECL Plus, Amersham Biosciences).
Electrophoretic mobility shift assay. Electrophoretic mobility shift assay (EMSA) was performed as previously described 40 , using the 32 P-labeled Pdx-1 binding region (GCCCTAATGGGC) of the human insulin promoter as a probe and crude nuclear extracts of NAKT-15 cells. For the super-shift experiment, 1 mg of rabbit anti-Pdx-1 antibody (Chemicon) was added to the reaction mixture. The competition assay was also carried out by further addition of 100-fold cold probes, wild and mutant (GCCAAAAAAGGC) types, to the reaction mixtures. The band was detected by radiography.
Immunostaining of insulin and Pdx-1 in NAKT-15 cells. Reverted NAKT-15 cells cultured on Matrigel were fixed with 4% paraformaldehyde and incubated with guinea pig anti-insulin antibody (DakoCytomation) and rabbit anti-Pdx-1 (Chemicon) followed by Cy2-or Cy3-labeled secondary antibody (Amersham Biosciences). Samples were observed under a confocal laser scanning microscope (LSM510; Carl Zeiss).
Immunoelectron microscopy. Reverted NAKT-15 cells (PDL 220-240), transplanted NAKT-15 cells and normal human pancreatic islets were fixed with 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. The samples were embedded in LR White (London Resin Company). Ultrathin sections on nickel grids were incubated with 6 M urea in 0.1 M glycine-HCl buffer (pH 3.5) for 5 min to etch the surface of sections. The grids were incubated with polyclonal guinea pig anti-swine insulin antibodies (DakoCytomation) at 4 1C overnight. After washing, the grids were incubated for 1.5 h with 10-nm colloidal gold-conjugated goat anti-guinea pig IgG (British Biocell International). The grids were washed, postfixed with 2% glutaraldehyde, rinsed with ddH 2 O and dried. The sections were stained with 2% uranyl acetate for 15 min and 3% lead citrate for 1 min, and observed with a Hitachi H-7100 transmission electron microscope.
Measurement of insulin and C-peptide. Reverted NAKT-15 cells (5 Â 10 5 ) at PDL 130-150, 220-240 or 310-330 were seeded in a culture dish containing Matrigel and cultured using serum-and insulin-free culture medium (ISE-RPMI). Cells were then cultured in medium containing various concentrations of glucose (5.6-25 mM) for 60 min or various secretagogues in the presence of low (5.6 mM), medium (10 mM) or high (25 mM) glucose for 30 min. Secretagogues included GLP-1 (10 nM), palmitate (500 mM), tolbutamide (100 mM), forskolin (10 mM) or KCl (30 mM). Insulin secretion into the medium was measured by enzyme-linked immunosorbent assay (ELISA) using an Ultrasensitive Insulin ELISA kit (Mercodia). Insulin and C-peptide content in the cell extracts were measured by ELISA and radioimmunoassay, respectively (Mitsubishi Kagaku Bio-Clinical Laboratories). To measure secreted insulin and C-peptide in the serum of mice transplanted with NAKT-15 cells or human islets, we fasted mice for 6 h and took blood samples at 30 min after glucose injection (1 g/kg body weight, intraperitoneally (i.p.)). For measurement of mouse insulin and C-peptide in vivo, a mouse insulin ELISA kit (Mercodia) and mouse C-peptide ELISA kit (Shibayagi) was used.
Transplantation of reverted NAKT-15 cells into diabetic SCID mice. Diabetes was induced in 8-week-old female Balb/c SCID mice (CLEA Japan) by streptozotocin (Sigma; 220 mg/kg body weight in citrate buffer, pH 4.5, i.p.). Animals with blood glucose levels Z 350 mg/dl for two consecutive days (n ¼ 10) were transplanted with reverted NAKT-15 cells (3 Â 10 6 ) into the left subrenal capsule, and blood glucose levels were measured. As a control, normal human islets (2,000) were transplanted. Kidneys, pancreata and livers were removed at 12 or 30 weeks after transplantation and fixed in formalin. Immunostaining was performed on 5-mm sections using guinea pig anti-insulin antibody or rabbit anti-glucagon antibody (DakoCytomation) followed by Cy2-or Cy-3-labeled secondary antibody (Amersham). Glucose tolerance tests were performed after injection of glucose (1 g/kg body weight, i.p.). Diabetic SCID mice transplanted with human islets and normal SCID mice served as positive controls.
Evaluation of tumorigenicity of NAKT-15 cells and reverted cells. NAKT-15 cells (1 Â 10 6 ) or reverted NAKT-15 cells (1 Â 10 6 ) were subcutaneously transplanted into 8-week-old female SCID mice (CLEA Japan), and tumor formation was observed for 6 months. MIN6m9 cells, a mouse insulinoma cell line, were used as a positive control.
Chromosome analysis. Chromosome analysis of the immortalized and reverted NAKT-15 cells was performed by Giemsa staining as previously reported 41 .
Assay for in vitro sensitivity of NAKT-15 cells to ganciclovir. To examine the in vitro sensitivity of NAKT-15 cells to ganciclovir (kindly donated by Tanabe Pharmaceutical), the cells were inoculated at 3 Â 10 3 cells per well and maintained in medium containing 5 mM ganciclovir to obtain a growth curve. On days 1, 3, 5 and 7, 2 mg of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each well, incubated for 4 h at 37 1C, and reacted with 150 ml isopropanol for 10 min. The relative percent viability was determined by the ratio of absorbance of 570 and 630 nm using a Bio-Rad EIA reader.
Statistical analyses. An ANOVA test was used to calculate the significance in mean values. The Kaplan-Meier method was used to calculate the survival data, and the significance was determined by the Mann-Whitney U test. P o 0.05 was considered statistically significant.
Note: Supplementary information is available on the Nature Biotechnology website.
